This text is a result of machine translation.
Cancer cell therapy company raised CNY 500 million in D round
Novozyme plus R-CHOP Regimen for first-line treatment of mantle cell lymphoma
Bh009 new drug project independently researched and developed by Beihai biological Co., Ltd. was approved by China's clinical trials
Qiuzhen medical and tianguangshi have reached strategic cooperation to develop diagnostic kits and tumor drugs
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Healthcare, Real Estate, IndustrialsTech for Global, Globalization Footprints of the Established and the New
Research
Industrials, Financials, Consumer StaplesLow-Carbon Industry Expansion - Key Studies From Chinese Companies
Sinopharm new coronavirus vaccine approved
Another protein component special medical food was approved, and the total number of approved products increased to 57
Phase I project of Guangzhou Pharmaceutical production base of nuocheng Jianhua was completed
BGI and Hanwei intelligent medical jointly launched mobile "two cancer" intelligent screening
Asc41, a candidate drug for NASH, was administered to overweight and obese subjects in phase IB clinical trial
Fosun medicine: the new crown vaccine has been included in the domestic phase II clinical, and no serious adverse report has been received
Cell and gene therapy cro / cdmo xuanming cells completed a round of financing, led by Huagai capital and juming venture capital
Improving service quality and enabling industrial innovation!
Pfizer submitted to FDA for authorization of emergency use of new crown vaccine
Baiji Shenzhou: midterm analysis of the global phase III clinical trial for the treatment of non-small cell lung cancer reached the main end point
Hillhouse Will Inject USD 1 billion in BeiGene's Share Sale
Huawei 'Strikes Back': Global 5G Patent Battle Might Be Getting Started
Apr 18, 2021 10:53 PM
Digital Currency Electronic Payment: Not A Warning Sign for Alipay and WeChat Pay
Apr 16, 2021 10:07 AM
Three Opportunities Brought by Archegos Capital's Outburst
Apr 12, 2021 12:31 PM